-
Big Movers: Pandora Media Inc (NYSE:P), Achillion Pharmaceuticals(NASDAQ:ACHN), Brady Corp. (NYSE:BRC), Xenith Bankshares(NASDAQ:XBKS), Silver Spring Networks(NYSE:SSNI)
Pandora Media Inc (NYSE:P), the leading internet radio service, announced that Chris Phillips has been named Chief Product Officer and will serve on the company’s Executive Leadership Team. Phillips and the product team will be responsible for defining and leading Pandora’s overarching product strategy and roadmap. He will partner with CTO Chris Martin and the…
-
Why Need to Watch: Borderfree(NASDAQ:BRDR), Achillion Pharmaceuticals(NASDAQ:ACHN), FTD Companies(NASDAQ:FTD), Cascade Bancorp (NASDAQ:CACB), DragonWave Inc. (NASDAQ:DRWI)
Borderfree Inc. (NASDAQ:BRDR) a MARKET leader in international cross-border ecommerce, on 22 October announced the appointment of Beth Pritchard to its Board of Directors. Borderfree, Inc. (NASDAQ:BRDR) in last trading activity advanced 6.65% to close at $10.91. Company weekly performance is -1.98% while its quarterly performance stands at -23.11%. Borderfree, Inc. (NASDAQ:BRDR) is -48.66% away…
-
Best Stocks: Achillion Pharmaceuticals(NASDAQ:ACHN), AT&T(NYSE:T), Ford Motor Company (NYSE:F), Google Inc (NASDAQ:GOOG), Verizon Communications Inc. (NYSE:VZ)
Achillion Pharmaceuticals Inc (NASDAQ:ACHN) has received an average recommendation of “Buy” from the nine analysts that are presently covering the stock, StockRatingsNetwork.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) in last trading activity increased 4.37% to…
-
Biotech Companies Spent 5 percent More On R&D Last Year – (QCOR, GILD, ARNA, ACHN)
The biotechnology industry’s spending on Research and development (R&D) moved up five percent last year, rebounding after a fall the prior year. BDO USA, LLP, an accounting and consulting organization, provided a new study showing that, on average, biotech companies spent $50 million on R&D in 2011, higher from just over $47 million invested in…